NovaVive Inc. - Equine

Home
Canada
Napanee, ON
NovaVive Inc. - Equine

Call Directions Website Contact the business

NovaVive offers regulator-approved equine immunotherapies in the USA, Canada, UAE, Australia and NZ. NovaVive Inc.

is an animal health immunobiology company with regulator-approved horse products available to veterinarians in CA, US, AU, and NZ.

10/31/2026

Endometritis involves more than simply determining whether bacteria are present.

Published research involving Settle® has evaluated several components of the uterine environment, including pro-inflammatory and anti-inflammatory cytokines, fluid retention, PMN infiltration and bacterial infiltration.

Examining these factors can provide researchers and veterinarians with a more complete understanding of the inflammatory and immune response
associated with endometritis.

Settle® is an immunotherapeutic approved as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus.

Explore NovaVive’s published equine research at NovaVive.ca/equine-research.

10/27/2026

Immunocidin® Equine is administered intratumorally, meaning the immunotherapeutic is administered directly into the sarcoid.

Administration technique is an important consideration when treating individual tumors, and NovaVive provides veterinarians with an administration video demonstrating the recommended approach.

Immunocidin® Equine is regulator-approved in the USA and Canada for the intratumoral treatment of equine sarcoids.

Visit NovaVive.ca/products and select Immunocidin® Equine to access product information, treatment results and administration resources.

10/23/2026

Endometritis can present a reproductive management challenge, particularly in mares that have difficulty clearing inflammation, fluid and bacteria from the uterus. This is not a condition you can see when looking at a mare, but it can be a significant barrier to successful reproduction.

Veterinarians may consider multiple factors when evaluating a susceptible mare.

Settle® is an MCWF immunostimulant approved as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus, providing veterinarians with an immunotherapeutic option for managing affected mares.

Learn more at NovaVive.ca/products or explore published research at NovaVive.ca/equine-research.

10/19/2026

Sarcoid response to treatment isn’t always immediate — and continued evaluation is an important part of the treatment process.

In a study evaluating Immunocidin® Equine, 73% of treated sarcoids achieved complete regression, while 27% showed partial regression. Among responding horses, 94% remained tumor-free at the two-year follow-up.

These results help provide veterinarians with additional information when considering immunotherapy as part of their approach to equine sarcoids.

Immunocidin® Equine is regulator-approved in the USA and Canada for the intratumoral treatment of sarcoids.

Visit NovaVive.ca/products and select Immunocidin® Equine to explore treatment results, product information and veterinary resources.

10/16/2026

Fall competition schedules can mean increased travel, changing environments and greater contact with other horses.

For veterinarians managing horses through periods of increased exposure, ensuring an effective immune response is an important consideration.

Equimune® is an MCWF-based immunotherapeutic that works by stimulating antigen-presenting cells and enhancing production of Interleukin 1 (IL-1), helping amplify immune responses to antigens.

Learn more about Equimune® and its role in equine health at NovaVive.ca/products.

10/13/2026

Equine sarcoids can vary in location, size, type and clinical presentation — factors that may influence how veterinarians approach treatment.

Immunocidin® Equine provides veterinarians with an immunotherapeutic option that is regulator-approved in the USA and Canada for the intratumoral treatment of equine sarcoids.

For veterinarians interested in learning more, NovaVive provides product information, technical support and an administration video. Contact the Company for details - [email protected].

Visit NovaVive.ca/products and select Immunocidin® Equine.

10/11/2026

What happens after Equimune® is injected in your horse?

Its active ingredient stimulates antigen-presenting cells and enhances production of Interleukin 1 (IL-1), helping amplify immune responses to antigens.

This includes both cell-mediated immunity and humoral antibody responses — two important components of the horse’s immune response.

Understanding the mechanism behind an immunotherapeutic can help veterinarians determine when and how it may fit into an individual patient’s treatment strategy.

Explore the science behind Equimune® at NovaVive.ca/products.

10/09/2026

Not every mare responds to breeding-related inflammation in the same way.

Following breeding, a normal immune response helps clear the uterus. In some
mares, however, inflammation can persist, contributing to an environment that may
interfere with reproductive success.

These mares may require additional evaluation and management to address the
factors contributing to delayed uterine clearance.

Settle® is an MCWF immunostimulant approved as an aid in the treatment of equine
endometritis (inflammation), providing veterinarians with an option for affected
mares.

Explore product information and published reproductive research at NovaVive.-
ca/equine-research.

09/28/2026

Endometritis can be an important consideration in reproductive management, particularly for mares that have difficulty clearing inflammation, fluid and bacteria from the uterus.

Following breeding, veterinarians may evaluate factors such as uterine fluid retention, inflammation and the presence of bacteria when determining the appropriate approach for an individual mare.

Settle® is an MCWF immunostimulant approved as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus, providing veterinarians with an immunotherapeutic option for managing affected mares.

Learn more about Settle® and its role in equine reproductive health at NovaVive.ca/products or NovaVive.ca/equine-research.

09/24/2026

Grooming is about more than a clean coat. Regular hands-on grooming gives owners, trainers and veterinary teams an opportunity to notice new or changing skin lesions, including sarcoids.

Immunocidin® Equine is approved in the U.S. and Canada for the intratumoral treatment of sarcoid tumors in horses.

If you notice a new mass, bump or skin change, talk with your veterinarian about an appropriate evaluation and treatment plan.

Download the product brochure and learn more at NovaVive.ca/products.

Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Telephone

1-613-308-9788

Website

http://www.NovaVive.ca/

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Equine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.